MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA
申请人:AstraZeneca AB
公开号:EP2285798A1
公开(公告)日:2011-02-23
[EN] MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA<br/>[FR] AGONISTES DES RÉCEPTEURS MUSCARINIQUES UTILES DANS LE TRAITEMENT DE LA DOULEUR, DE LA MALADIE D'ALZHEIMER ET DE LA SCHIZOPHRÉNIE
申请人:ASTRAZENECA AB
公开号:WO2009136850A1
公开(公告)日:2009-11-12
Compounds of Formula (I), or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4, m, n, q, s, t, X, and Y are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
REACTIONS OF α-HETEROATOM-SUBSTITUTED ETHERS AND SULFIDES WITH SILYL ENOL ETHERS. CHEMOSELECTIVITY IN THE CLEAVAGE OF HETEROATOM–CARBON BONDS BY IODOTRIMETHYLSILANE AND TRIMETHYLSILYL TRIFLUOROMETHANESULFONATE
作者:Akira Hosomi、Yasuyuki Sakata、Hideki Sakurai
DOI:10.1246/cl.1983.405
日期:1983.3.5
Reactions of α-heteroatom-substituted ethers and relatedcompounds (R1R2CXY; X, Y = RO, RS and Cl) with silyl enol ethers and ketene silyl acetals took place in the presence of iodotrimethylsilane (Ia) and trimethylsilyl triflate (Ib) as a catalyst and factors influencing the activation of the heteroatom by I were examined.